Clinical Trial Update: DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating DHA-paclitaxel in patients with metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DHA-paclitaxel

Snippet

Sponsor: Theradex | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN